Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WW domain-containing oxidoreductase (WWOX) is a tumor suppressor protein that plays a critical role in apoptosis, development, and cellular stress responses. It contains two N-terminal WW domains and a C-terminal short-chain dehydrogenase/reductase (SDR) domain. WWOX interacts with numerous proteins via its WW domains, influencing various cellular pathways. Loss of WWOX expression is frequently observed in many cancers, suggesting its importance in maintaining genomic stability and preventing tumor development.
WWOX acts as a tumor suppressor by inducing apoptosis and inhibiting tumor growth. It functions as an adaptor protein via its WW domains, interacting with various signaling proteins containing PPxY motifs. The SDR domain is involved in redox reactions, particularly with steroid substrates.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WW domain-containing oxidoreductase (WWOX).